This protocol is judged by an institutional evaluation board, an independent team that reviews any clinical trials involving individuals. If a research includes a Schedule I drug, after the board approves the protocol as moral, the researchers have to make an application for an investigational new drug (IND) amount in the FDA.And For the reason th